ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Ambulatory Health Care Facilities, Rural Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,304Medicare Part D Prescriptions Filled, Including Refills
$684K Total Retail Price of All Prescriptions
352 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 515 271 S3
LISINOPRIL 397 270
FUROSEMIDE 396 268
SIMVASTATIN 373 286
OMEPRAZOLE 320 203
AMLODIPINE BESYLATE 317 251
METFORMIN HCL 292 172
LEVOTHYROXINE SODIUM 286 257
RANITIDINE HCL 230 122
METOPROLOL TARTRATE 218 149
CARISOPRODOL 202 57 R
GABAPENTIN 196 129
HYDROCHLOROTHIAZIDE 195 142
POTASSIUM CHLORIDE 179 130
MELOXICAM 176 117
CARVEDILOL 174 112
METOPROLOL SUCCINATE 145 115
ZOLPIDEM TARTRATE 145 67
ALLOPURINOL 139 92
CLOPIDOGREL 128 103
TRAMADOL HCL 122 82
NAPROXEN 115 58
GEMFIBROZIL 114 59
SERTRALINE HCL 111 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 80
GLIMEPIRIDE 103 57
NEXIUM 103 33
CRESTOR 102 47
AMITRIPTYLINE HCL 101 67 R
ADVAIR DISKUS 100 46
CELEBREX 99 68
CITALOPRAM HBR 97 45
CYMBALTA 97 22
AMLODIPINE BESYLATE-BENAZEPRIL 95 41
AZITHROMYCIN 93 51
TAMSULOSIN HCL 91 65
ZETIA 87 59
SINGULAIR 86 59
DIOVAN 85 29
PROAIR HFA 83 39
EVISTA 83 74
CLONIDINE HCL 79 30
PLAVIX 77 56
PRAVASTATIN SODIUM 76 68
DONEPEZIL HCL 76 75
SPIRIVA 75 38
ATORVASTATIN CALCIUM 75 74
FLUTICASONE PROPIONATE 75 26
LOVASTATIN 68 55
ALENDRONATE SODIUM 68 61
PANTOPRAZOLE SODIUM 67 47
NAMENDA 65 52
DIOVAN HCT 64 25
TERAZOSIN HCL 63 53
PROMETHAZINE HCL 60 33 R
LYRICA 60 22
CYCLOBENZAPRINE HCL 57 26 R
WARFARIN SODIUM 54 39
LEVOFLOXACIN 52 34
PRENATAL PLUS 50 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.